Hallucination News and Research

RSS

A hallucination, in the broadest sense of the word, is a perception in the absence of a stimulus. In a stricter sense, hallucinations are defined as perceptions in a conscious and awake state in the absence of external stimuli which have qualities of real perception, in that they are vivid, substantial, and located in external objective space.

Older first time mothers more prone to develop mental illness

Swedish researchers have revealed that women who have their first baby after age 35 are more likely to develop a mental illness after the birth.

10 Feb 2009

Discovery of new schizophrenia gene

Researchers at the Johns Hopkins University School of Medicine are one gene closer to understanding schizophrenia and related disorders.

3 Feb 2009

New findings on schizophrenia

Schizophrenia may blur the boundary between internal and external realities by overactivating a brain system that is involved in self-reflection, and thus causing an exaggerated focus on self, a new MIT and Harvard brain imaging study has found.

21 Jan 2009

Schizophrenia and bipolar disorder have same genetic causes

Schizophrenia and bipolar disorder have for decades been regarded as two distinct psychotic disorders when it comes to definitions and risk factors.

21 Jan 2009

Altered brain activity in schizophrenia may direct focus on self

19 Jan 2009

Too much coffee can lead to hallucinations

According to a study by researchers at Durham University people with a higher caffeine intake, from coffee, tea and caffeinated energy drinks, are more likely to experience hallucinatory experiences such as hearing voices and seeing things that are not there.

18 Jan 2009

High caffeine consumption linked to hallucinations

High caffeine consumption could be linked to a greater tendency to hallucinate, a new research study suggests.

13 Jan 2009

Lilly receives complete response letter for Olanzapine LAI for treatment of schizophrenia

Eli Lilly and Company has announced that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in adults.

7 Jan 2009

Paliperidone palmitate shows positive results for treatment of schizophrenia

Paliperidone palmitate, an investigational long-acting therapy (LAT) demonstrated statistically significant symptom control compared with placebo according to the results of a 13-week study.

14 Dec 2008

Parkinson's disease can also affect changes in thought, behavior and judgment

Parkinson's disease affects 6.3 million people worldwide. While the disease is recognized for its profound effects on movement, up to 40 percent of Parkinson's disease patients also develop changes in thought, behavior and judgment.

14 Dec 2008

AstraZeneca and Targacept announce results from trial of AZD3480 for cognitive dysfunction in schizophrenia

AstraZeneca and Targacept, Inc. havey announced top-line results from a Phase IIb clinical trial of AZD3480 (TC-1734) conducted by AstraZeneca in cognitive dysfunction in schizophrenia (CDS), known as the HALO trial.

10 Dec 2008

Men have more red in their faces and women have more green

Michael J. Tarr, a Brown University scientist, and graduate student Adrian Nestor have discovered this color difference in an analysis of dozens of faces.

8 Dec 2008

New data demonstrates efficacy and tolerability of Carisbamate as an adjunctive therapy for partial onset seizures

Phase III data on carisbamate, an investigational compound recently filed with the FDA for the adjunctive treatment of partial onset seizures (POS) in patients 16 years of age and older, was presented during the poster sessions of the 32nd Annual Meeting of the American Epilepsy Society.

7 Dec 2008

Warning of serious side-effects of quit-smoking drug Champix

Australian doctors have been warned about the the quit-smoking drug Champix, according to the Therapeutic Goods Administration (TGA) care must be taken when prescribing Champix (varenicline), because of possible serious side-effects.

2 Dec 2008

Kynurenic acid in brain shows potential as schizophrenia target

New research has traced elevated levels of a specific compound in the brain to problem-solving deficits in patients with schizophrenia.

18 Nov 2008

Link found between brain receptors and schizophrenia

Scientists at Newcastle University in the UK have revealed a link between schizophrenia and a lack of specific brain receptors.

28 Oct 2008

Lack of brain NMDA receptors linked to schizophrenia

A lack of specific brain receptors has been linked with schizophrenia in new research by scientists at Newcastle University.

27 Oct 2008

Brain-derived neurotrophic factor may predict schizophrenia relapse

A factor that helps optimize brain formation and function may also provide clues about whether patients suffering with schizophrenia are headed toward relapse, researchers say.

16 Oct 2008

Drugs to treat ADHD should be a last resort

According to new guidelines in Britain on attention deficit hyperactivity disorder (ADHD), drugs should be the last resort in treating the disorder and parents need to learn how to cope with their child's unruly behaviour.

24 Sep 2008

Hallucinations in the flash of an eye

Ever seen or heard something that wasn't there? For most of us such experiences - termed hallucinations - are a normal, fleeting, brain glitch; yet for a few they are persistent, distressing and associated with a range of psychiatric, neurological and eye conditions.

4 Sep 2008